EcoDrugPlus

Adam Metallopeptidase With Thrombospondin Type 1 Motif 5

Ensembl ID : ENSOTSG00005045693
Gene Symbol: ADAMTS5
3 Cross references
192 Possible Orthologues:

Adam Metallopeptidase With Thrombospondin Type 1 Motif 5

Ensembl ID : ENSOTSG00005046524
Gene Symbol: ADAMTS5
3 Cross references
192 Possible Orthologues:

Adam Metallopeptidase With Thrombospondin Type 1 Motif 5

Ensembl ID : ENSOTSG00005013665
Gene Symbol: ADAMTS5
3 Cross references
192 Possible Orthologues:

Adrm1 26s Proteasome Ubiquitin Receptor

Ensembl ID : ENSOTSG00005026852
Gene Symbol: ADRM1
1 Cross references
186 Possible Orthologues:

Adrm1 26s Proteasome Ubiquitin Receptor

Ensembl ID : ENSOTSG00005044900
Gene Symbol: ADRM1
1 Cross references
194 Possible Orthologues:

Akt Serine/threonine Kinase 1

Ensembl ID : ENSOTSG00005005166
Gene Symbol: AKT1
3 Cross references
180 Possible Orthologues:

Akt Serine/threonine Kinase 1

Ensembl ID : ENSOTSG00005040173
Gene Symbol: AKT1
3 Cross references
144 Possible Orthologues:

Akt Serine/threonine Kinase 1

Ensembl ID : ENSOTSG00005028362
Gene Symbol: AKT1
3 Cross references
144 Possible Orthologues:

Akt Serine/threonine Kinase 1

Ensembl ID : ENSOTSG00005016877
Gene Symbol: AKT1
3 Cross references
181 Possible Orthologues:

Aph1b Gamma Secretase Subunit

Ensembl ID : ENSOTSG00005041035
Gene Symbol: APH1B
1 Cross references
184 Possible Orthologues:

Atp Binding Cassette Subfamily B Member 1

Ensembl ID : ENSOTSG00005015147
Gene Symbol: ABCB1
1 Cross references
164 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 8

Ensembl ID : ENSOTSG00005017075
Gene Symbol: ABCC8
1 Cross references
223 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).